Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
828,293
-
Share change
-
+236,573
-
Total reported value
-
$1,562,243
-
Price per share
-
$1.88
-
Number of holders
-
30
-
Value change
-
+$487,963
-
Number of buys
-
16
-
Number of sells
-
11
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2020
As of 30 Jun 2020,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
828,293 shares.
The largest 10 holders included
WEDBUSH SECURITIES INC, TWO SIGMA ADVISERS, LP, Creative Planning, CIBC World Markets Inc., ROYAL BANK OF CANADA, FINANCIAL CONSULATE, INC, CITADEL ADVISORS LLC, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, BANCO BILBAO VIZCAYA ARGENTARIA, S.A., and MORGAN STANLEY.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.